Philips Secures Critical United States Regulatory Approval for Next-Generation Cardiovascular Imaging Software
Dutch health technology multinational Philips has received highly sought-after authorization from the United States Food and Drug Administration to deploy its advanced, artificial intelligence-driven cardiovascular imaging software across American hospitals. The vital regulatory victory provides a massive financial boost for the Amsterdam-based conglomerate as it aggressively pivots toward high-margin digital health software.